Scott Miller of Greenhaven Road Capital presented his in-depth investment thesis on Cellebrite (US: CLBT) at Wide-Moat Investing Summit 2022.
Cellebrite, an Israel-based SPAC, is quantitatively inexpensive for a subscription-based business.
Scott views Cellebrite as a qualitatively attractive business with secular tailwinds and scale advantages, making it worth to “hold your nose” and venture into SPAC land.
Replay this LIVE session:
About the instructor:
Scott Miller is the founder of Greenhaven Road Capital, a boutique investment partnership that seeks out off the beaten path investments, modeled after the early Buffett partnerships. The firm is built on the belief that a focused investment manager can outperform an index by limiting fund capacity and by concentrating exposure on a few great ideas over a long time horizon. Experience as an owner-operator of businesses influence Greenhaven’s approach towards partially-owning companies rather than merely picking stocks. Prior to founding Greenhaven Road, Scott co-founded Acelero Learning, serving in a variety of roles over a decade from CFO to CTO, to Chief Strategy Officer to his current role of Board Member. Acelero Learning has grown from three people in an office “cube” in New York City to 1,500 employees serving 5,000 children across four states. Additionally, Scott managed a manufacturing business, with responsibility for hiring, firing, planning inventory, negotiating with suppliers and acquiring customers at a reasonable cost. Scott holds an MBA and a Masters in Education from Stanford University.